Cite
MLA Citation
I Noth et al.. “M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials.” Thorax, vol. 72, n.d., pp. A255–A257. http://access.bl.uk/ark:/81055/vdc_100137792070.0x00002b